2 results
Approved WMOWill not start
Primary: Dose escalation part: To determine the MTD and/or RP2D of PDR001 in combination with regorafenib in patients with metastatic MSS CRC. Expansion part: To evaluate the efficacy based on overall response rate (ORR) of PDR001 in combination…
Approved WMOCompleted
The objective of this study is to observe the anatomical and functional outcomes of ocriplasmin over a 6-month follow-up period.